Back to Search Start Over

The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report.

Authors :
de By TMMH
Schoenrath F
Veen KM
Mohacsi P
Stein J
Alkhamees KMM
Anastasiadis K
Berhnardt A
Beyersdorf F
Caliskan K
Reineke D
Damman K
Fiane A
Gkouziouta A
Gollmann-Tepeköylü C
Gustafsson F
Hulman M
Iacovoni A
Loforte A
Merkely B
Musumeci F
Němec P
Netuka I
Özbaran M
Potapov E
Pya Y
Rábago G
Ramjankhan F
Reichenspurner H
Saeed D
Sandoval E
Stockman B
Vanderheyden M
Tops L
Wahlers T
Zembala M
Zimpfer D
Carrel T
Gummert J
Meyns B
Source :
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2022 Jun 15; Vol. 62 (1).
Publication Year :
2022

Abstract

Objectives: In the third report of the European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery, outcomes of patients receiving mechanical circulatory support are reviewed in relation to implant era.<br />Methods: Procedures in adult patients (January 2011-June 2020) were included. Patients from centres with <60% follow-ups completed were excluded. Outcomes were stratified into 3 eras (2011-2013, 2014-2017 and 2018-2020). Adverse event rates (AERs) were calculated and stratified into early phase (<3 months) and late phase (>3 months). Risk factors for death were explored using univariable Cox regression with a stepwise time-varying hazard ratio (<3 vs >3 months).<br />Results: In total, 4834 procedures in 4486 individual patients (72 hospitals) were included, with a median follow-up of 1.1 (interquartile range: 0.3-2.6) years. The annual number of implants (range: 346-600) did not significantly change (P = 0.41). Both Interagency Registry for Mechanically Assisted Circulatory Support class (classes 4-7: 23, 25 and 33%; P < 0.001) and in-hospital deaths (18.5, 17.2 and 11.2; P < 0.001) decreased significantly between eras. Overall, mortality, transplants and the probability of weaning were 55, 25 and 2% at 5 years after the implant, respectively. Major infections were mainly noted early after the implant occurred (AER<3 months: 1.44 vs AER>3 months: 0.45). Bilirubin and creatinine levels were significant risk factors in the early phase but not in the late phase after the implant.<br />Conclusions: In its 10 years of existence, EUROMACS has become a point of reference enabling benchmarking and outcome monitoring. Patient characteristics and outcomes changed between implant eras. In addition, both occurrence of outcomes and risk factor weights are time dependent.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)

Details

Language :
English
ISSN :
1873-734X
Volume :
62
Issue :
1
Database :
MEDLINE
Journal :
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Publication Type :
Academic Journal
Accession number :
35150247
Full Text :
https://doi.org/10.1093/ejcts/ezac032